Global Head, Office of Technology & Innovation
Pete Milligan is responsible for a number of critical change programmes to transform the way GlaxoSmithKline collects, reports, archives, and retrieves clinical trials data, involving different types of change (people, process, technology, and standards). He has considerable experience in business process, technology strategy and change management.
He has led a number of major performance improvement and cost reduction projects during his tenure at GSK. He led the diagnosis and design effort preceding the investment in one of GSKs largest recent change initiatives – Simplifying Clinical Development. Recognised as a thought leader for the strategy and design GSK is now executing.
Peter began his career at the Wellcome Foundation in 1989 and has led the design, implementation, and support for many of the clinical, medical, Pharmacovigilence and regulatory systems used in Research and Development.